213 related articles for article (PubMed ID: 28055972)
1. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.
Yu H; Jiang Y; Liu L; Shan W; Chu X; Yang Z; Yang ZQ
Oncotarget; 2017 Feb; 8(8):13099-13115. PubMed ID: 28055972
[TBL] [Abstract][Full Text] [Related]
2. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
Jiang Y; Liu L; Shan W; Yang ZQ
Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
[TBL] [Abstract][Full Text] [Related]
3. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.
Liu L; Kimball S; Liu H; Holowatyj A; Yang ZQ
Oncotarget; 2015 Feb; 6(4):2466-82. PubMed ID: 25537518
[TBL] [Abstract][Full Text] [Related]
5. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
[TBL] [Abstract][Full Text] [Related]
6. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
[TBL] [Abstract][Full Text] [Related]
7. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.
Wu X; Zhu Z; Li W; Fu X; Su D; Fu L; Zhang Z; Luo A; Sun X; Fu L; Dong JT
Breast Cancer Res; 2012 May; 14(3):R73. PubMed ID: 22569290
[TBL] [Abstract][Full Text] [Related]
8. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
9. Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2.
Rantala JK; Edgren H; Lehtinen L; Wolf M; Kleivi K; Vollan HK; Aaltola AR; Laasola P; Kilpinen S; Saviranta P; Iljin K; Kallioniemi O
Neoplasia; 2010 Nov; 12(11):877-88. PubMed ID: 21082043
[TBL] [Abstract][Full Text] [Related]
10. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.
Sun M; Song CX; Huang H; Frankenberger CA; Sankarasharma D; Gomes S; Chen P; Chen J; Chada KK; He C; Rosner MR
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9920-5. PubMed ID: 23716660
[TBL] [Abstract][Full Text] [Related]
11. Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer.
Dexter TJ; Sims D; Mitsopoulos C; Mackay A; Grigoriadis A; Ahmad AS; Zvelebil M
BMC Syst Biol; 2010 Sep; 4():127. PubMed ID: 20825665
[TBL] [Abstract][Full Text] [Related]
12. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
13. Transforming properties of 8p11-12 amplified genes in human breast cancer.
Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.
Graham TR; Yacoub R; Taliaferro-Smith L; Osunkoya AO; Odero-Marah VA; Liu T; Kimbro KS; Sharma D; O'Regan RM
Breast Cancer Res Treat; 2010 Aug; 123(1):139-47. PubMed ID: 19921427
[TBL] [Abstract][Full Text] [Related]
15. EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.
Katsyv I; Wang M; Song WM; Zhou X; Zhao Y; Park S; Zhu J; Zhang B; Irie HY
Oncotarget; 2016 Oct; 7(43):69592-69605. PubMed ID: 27612429
[TBL] [Abstract][Full Text] [Related]
16. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers.
Natrajan R; Weigelt B; Mackay A; Geyer FC; Grigoriadis A; Tan DS; Jones C; Lord CJ; Vatcheva R; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Reis-Filho JS
Breast Cancer Res Treat; 2010 Jun; 121(3):575-89. PubMed ID: 19688261
[TBL] [Abstract][Full Text] [Related]
17. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.
Basu M; Sengupta I; Khan MW; Srivastava DK; Chakrabarti P; Roy S; Das C
Biochem J; 2017 May; 474(11):1919-1934. PubMed ID: 28432260
[TBL] [Abstract][Full Text] [Related]
18. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.
Montes de Oca R; Gurard-Levin ZA; Berger F; Rehman H; Martel E; Corpet A; de Koning L; Vassias I; Wilson LO; Meseure D; Reyal F; Savignoni A; Asselain B; Sastre-Garau X; Almouzni G
Mol Oncol; 2015 Mar; 9(3):657-74. PubMed ID: 25497280
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs.
Kim SW; Fishilevich E; Arango-Argoty G; Lin Y; Liu G; Li Z; Monaghan AP; Nichols M; John B
PLoS One; 2015; 10(3):e0120296. PubMed ID: 25798919
[TBL] [Abstract][Full Text] [Related]
20. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
Weigman VJ; Chao HH; Shabalin AA; He X; Parker JS; Nordgard SH; Grushko T; Huo D; Nwachukwu C; Nobel A; Kristensen VN; Børresen-Dale AL; Olopade OI; Perou CM
Breast Cancer Res Treat; 2012 Jun; 133(3):865-80. PubMed ID: 22048815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
